Key statistics
As of last trade I-Mab (0VY:FRA) traded at 0.985, 7.65% above its 52-week low of 0.915, set on Sep 09, 2024.
52-week range
Open | 0.985 |
---|---|
High | 0.985 |
Low | 0.985 |
Bid | 0.99 |
Offer | 1.07 |
Previous close | 0.965 |
Average volume | 80.71 |
---|---|
Shares outstanding | 80.88m |
Free float | 80.07m |
P/E (TTM) | -- |
Market cap | 88.97m USD |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Nov 11 2024 07:28 GMT.
More ▼
Press releases
- I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer
- Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation
- I-Mab to Release Q3 2024 Financial Results on November 14, 2024
- I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024
- I-Mab to Participate at the Truist Securities BioPharma Symposium
- I-Mab Presents Updated Phase 1 Givastomig Data at ESMO 2024
- I-Mab Presents Positive Uliledlimab Pharmacokinetics Data at 2024 World Conference on Lung Cancer
- I-Mab Reports 1H 2024 Financial Results, Pipeline Progress, and Business Updates
- I-Mab to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
- I-Mab to Release 1H 2024 Financial Results on August 28, 2024
More ▼